GLI2 and cancer: Similarly, GLI1 (Figure 5D), GLI2 (Figure 5E), and GLI3 (Figure 5F) were identified as prognostic risk factors for patients with 9, 8, and 6 types of cancer, respectively, using progression-free interval (PFI) analyses.